Bolt Biotherapeutics Inc. (BOLT)
NASDAQ
Bolt Biotherapeutics Inc. Total Liabilities 2020–2025
Bolt Biotherapeutics Inc. annual/quarterly total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Bolt Biotherapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 30.2M, a 28.73% decrease year-over-year.
- Bolt Biotherapeutics Inc. total liabilities for 2025 were 30.2M, a 28.73% decrease from 2024.
- Bolt Biotherapeutics Inc. total liabilities for 2024 were 42.4M, a 9.80% decrease from 2023.
- Bolt Biotherapeutics Inc. total liabilities for 2023 were 47.0M, a 16.44% decrease from 2022.
- Bolt Biotherapeutics Inc. total liabilities for 2022 were 56.3M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Bolt Biotherapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $30 |
| 2024 | $42 |
| 2023 | $47 |
| 2022 | $56 |
| 2021 | $58 |
| 2020 | $46 |
| Bolt Biotherapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $30 |
| 2024-12-31 | $42 |
| 2023-12-31 | $47 |
| 2022-12-31 | $56 |
| 2021-12-31 | $58 |
| 2020-12-31 | $46 |
Bolt Biotherapeutics Inc. Total Liabilities — FAQ
Bolt Biotherapeutics Inc. (BOLT) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BOLT's total liabilities history?
The chart and table above show Bolt Biotherapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.